BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gómez-Oliva R, Domínguez-García S, Carrascal L, Abalos-Martínez J, Pardillo-Díaz R, Verástegui C, Castro C, Nunez-Abades P, Geribaldi-Doldán N. Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments. Front Oncol 2020;10:614295. [PMID: 33585240 DOI: 10.3389/fonc.2020.614295] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Mariappan A, Knauth T, Pallini R, Gopalakrishnan J. A Three-Dimensional Organoid Culture System to Model Invasive Patterns of Patient-Derived Glioma Stem Cells. Neuromethods 2023. [DOI: 10.1007/978-1-0716-2720-4_8] [Reference Citation Analysis]
2 Wanigasekara J, Cullen PJ, Bourke P, Tiwari B, Curtin JF. Advances in 3D culture systems for therapeutic discovery and development in brain cancer. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.103426] [Reference Citation Analysis]
3 Lee S, Weiss T, Bühler M, Mena J, Lottenbach Z, Wegmann R, Bihl M, Augustynek B, Baumann S, Goetze S, van Drogen A, Vasella F, Rushing EJ, Wollscheid B, Hediger MA, Weller M, Snijder B. Targeting tumour-intrinsic neural vulnerabilities of glioblastoma.. [DOI: 10.1101/2022.10.07.511321] [Reference Citation Analysis]
4 Jubelin C, Muñoz-garcia J, Griscom L, Cochonneau D, Ollivier E, Heymann M, Vallette FM, Oliver L, Heymann D. Three-dimensional in vitro culture models in oncology research. Cell Biosci 2022;12:155. [DOI: 10.1186/s13578-022-00887-3] [Reference Citation Analysis]
5 Karve AS, Desai JM, Dave N, Wise-Draper TM, Gudelsky GA, Phoenix TN, DasGupta B, Sengupta S, Plas DR, Desai PB. Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole. Cancer Chemother Pharmacol 2022. [PMID: 36050497 DOI: 10.1007/s00280-022-04469-5] [Reference Citation Analysis]
6 Shen Y, Hu M, Li W, Chen Y, Xu Y, Sun L, Liu D, Chen S, Gu Y, Ma Y, Chen X. Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy. J Control Release 2022;350:158-74. [PMID: 35981634 DOI: 10.1016/j.jconrel.2022.08.019] [Reference Citation Analysis]
7 D'agostino S, Rimann M, Gamba P, Perilongo G, Pozzobon M, Raghunath M. Macromolecular crowding tuned extracellular matrix deposition in a bioprinted human rhabdomyosarcoma model. Bioprinting 2022;27:e00213. [DOI: 10.1016/j.bprint.2022.e00213] [Reference Citation Analysis]
8 McInerney CE, Lynn JA, Gilmore AR, Flannery T, Prise KM. Using AI-Based Evolutionary Algorithms to Elucidate Adult Brain Tumor (Glioma) Etiology Associated with IDH1 for Therapeutic Target Identification. Curr Issues Mol Biol 2022;44:2982-3000. [PMID: 35877430 DOI: 10.3390/cimb44070206] [Reference Citation Analysis]
9 Taiarol L, Bigogno C, Sesana S, Kravicz M, Viale F, Pozzi E, Monza L, Carozzi VA, Meregalli C, Valtorta S, Moresco RM, Koch M, Barbugian F, Russo L, Dondio G, Steinkühler C, Re F. Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics. Cancers (Basel) 2022;14:2978. [PMID: 35740641 DOI: 10.3390/cancers14122978] [Reference Citation Analysis]
10 Mosteiro A, Pedrosa L, Ferrés A, Diao D, Sierra À, González JJ. The Vascular Microenvironment in Glioblastoma: A Comprehensive Review. Biomedicines 2022;10:1285. [DOI: 10.3390/biomedicines10061285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Adjei-Sowah EA, O'Connor SA, Veldhuizen J, Lo Cascio C, Plaisier C, Mehta S, Nikkhah M. Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single-Cell Resolution using a Microfluidic Tumor Microenvironment Model. Adv Sci (Weinh) 2022;:e2201436. [PMID: 35619544 DOI: 10.1002/advs.202201436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Leong SW, Tan SC, Norhayati MN, Monif M, Lee SY. Effectiveness of Bioinks and the Clinical Value of 3D Bioprinted Glioblastoma Models: A Systematic Review. Cancers (Basel) 2022;14:2149. [PMID: 35565282 DOI: 10.3390/cancers14092149] [Reference Citation Analysis]
13 Bianconi A, Aruta G, Rizzo F, Salvati LF, Zeppa P, Garbossa D, Cofano F. Systematic Review on Tumor Microenvironment in Glial Neoplasm: From Understanding Pathogenesis to Future Therapeutic Perspectives. IJMS 2022;23:4166. [DOI: 10.3390/ijms23084166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rameshwar P, Savanur VH, Etchegaray J, Guvendiren M. 3D bioprinting as a designer organoid to assess pathological processes in translational medicine. Journal of 3D printing in medicine 2022;6:37-46. [DOI: 10.2217/3dp-2021-0006] [Reference Citation Analysis]
15 Batara DCR, Zhou S, Choi M, Kim S. Glioblastoma organoid technology: an emerging preclinical models for drug discovery. Organoid 2022;2:e7. [DOI: 10.51335/organoid.2022.2.e7] [Reference Citation Analysis]
16 Pacheco C, Martins C, Monteiro J, Baltazar F, Costa BM, Sarmento B. Glioblastoma Vasculature: From its Critical Role in Tumor Survival to Relevant in Vitro Modelling. Front Drug Deliv 2022;2. [DOI: 10.3389/fddev.2022.823412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Pacia CP, Yuan J, Yue Y, Xu L, Nazeri A, Desai R, Gach HM, Wang X, Talcott MR, Chaudhuri AA, Dunn GP, Leuthardt EC, Chen H. Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA. Theranostics 2022;12:362-78. [PMID: 34987650 DOI: 10.7150/thno.65597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 DePalma TJ, Sivakumar H, Skardal A. Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma. Adv Drug Deliv Rev 2022;180:114067. [PMID: 34822927 DOI: 10.1016/j.addr.2021.114067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Kaynar A, Altay O, Li X, Zhang C, Turkez H, Uhlén M, Shoaie S, Mardinoglu A. Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme. Int J Mol Sci 2021;22:13213. [PMID: 34948010 DOI: 10.3390/ijms222413213] [Reference Citation Analysis]
20 Abdullah KG, Bird CE, Buehler JD, Gattie LC, Savani MR, Sternisha AC, Xiao Y, Levitt MM, Hicks WH, Li W, Ramirez DMO, Patel T, Garzon-Muvdi T, Barnett S, Zhang G, Ashley DM, Hatanpaa KJ, Richardson TE, McBrayer SK. Establishment of patient-derived organoid models of lower grade glioma. Neuro Oncol 2021:noab273. [PMID: 34850183 DOI: 10.1093/neuonc/noab273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Dluska E, Markowska‐radomska A, Metera A, Rudniak L, Kosicki K. Mass transfer of anti‐cancer drug delivery to brain tumors by a multiple emulsion‐based implant. AIChE Journal 2022;68. [DOI: 10.1002/aic.17501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chang HG, Choi YH, Hong J, Choi JW, Yoon AR, Yun CO. GM101 in Combination with Histone Deacetylase Inhibitor Enhances Anti-Tumor Effects in Desmoplastic Microenvironment. Cells 2021;10:2811. [PMID: 34831034 DOI: 10.3390/cells10112811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Seifert C, Balz E, Herzog S, Korolev A, Gaßmann S, Paland H, Fink MA, Grube M, Marx S, Jedlitschky G, Tzvetkov MV, Rauch BH, Schroeder HWS, Bien-Möller S. PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells. Int J Mol Sci 2021;22:11126. [PMID: 34681783 DOI: 10.3390/ijms222011126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Wagner PM, Prucca CG, Caputto BL, Guido ME. Adjusting the Molecular Clock: The Importance of Circadian Rhythms in the Development of Glioblastomas and Its Intervention as a Therapeutic Strategy. Int J Mol Sci 2021;22:8289. [PMID: 34361055 DOI: 10.3390/ijms22158289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Han XX, Cai C, Yu LM, Wang M, Hu DY, Ren J, Zhang MH, Zhu LY, Zhang WH, Huang W, He H, Gao Z. A Fast and Efficient Approach to Obtaining High-Purity Glioma Stem Cell Culture. Front Genet 2021;12:639858. [PMID: 34295351 DOI: 10.3389/fgene.2021.639858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Geribaldi-Doldán N, Hervás-Corpión I, Gómez-Oliva R, Domínguez-García S, Ruiz FA, Iglesias-Lozano I, Carrascal L, Pardillo-Díaz R, Gil-Salú JL, Nunez-Abades P, Valor LM, Castro C. Targeting Protein Kinase C in Glioblastoma Treatment. Biomedicines 2021;9:381. [PMID: 33916593 DOI: 10.3390/biomedicines9040381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
27 Stanković T, Ranđelović T, Dragoj M, Stojković Burić S, Fernández L, Ochoa I, Pérez-García VM, Pešić M. In vitro biomimetic models for glioblastoma-a promising tool for drug response studies. Drug Resist Updat 2021;55:100753. [PMID: 33667959 DOI: 10.1016/j.drup.2021.100753] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]